These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 16309985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y.
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [Abstract] [Full Text] [Related]

  • 3. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 4. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 5. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
    Murase Y, Okahashi N, Koseki T, Itoh K, Udagawa N, Hashimoto O, Sugino H, Noguchi T, Nishihara T.
    J Cell Physiol; 2001 Aug 13; 188(2):236-42. PubMed ID: 11424090
    [Abstract] [Full Text] [Related]

  • 8. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y.
    Int Immunol; 2010 Oct 13; 22(10):805-16. PubMed ID: 20679512
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S, Yamaguchi M.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1297-305. PubMed ID: 15013845
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G, Anderson G, Jones A, De Ciechi P, Settle S, Mnich S, Thiede M, Abu-Amer Y, Portanova J, Monahan J.
    J Pharmacol Exp Ther; 2006 Jun 01; 317(3):1044-53. PubMed ID: 16501068
    [Abstract] [Full Text] [Related]

  • 17. Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro.
    Fox SW, Fuller K, Chambers TJ.
    J Cell Physiol; 2000 Sep 01; 184(3):334-40. PubMed ID: 10911364
    [Abstract] [Full Text] [Related]

  • 18. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W, Bar-Shavit Z.
    J Bone Miner Res; 2002 Jul 01; 17(7):1211-8. PubMed ID: 12096834
    [Abstract] [Full Text] [Related]

  • 19. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F, Matsubara T, Tsurukai T, Hata K, Nishimura R, Yoneda T.
    J Bone Miner Res; 2008 Jun 01; 23(6):907-14. PubMed ID: 18251700
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 01; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.